Skip to content
 
  • 1. About the programme
  • 2. Announcement
  • 3. Create application

Global Health- and Vaccination Research (GLOBVAC)

Deadline Announcement
14.02.2018
13:00 CET
Planned
NOK 67 million available for Global Health and Vaccination Research Choose

Objectives:

The primary objective of the programme is to support high-quality research with a potential for high impact that can contribute to sustainable improvements in health and health equity for people in low and lower-middle income countries (LLMICs).

Please note that low- and lower-middle income countries are defined in accordance with the OECD DAC list that includes the following categories: least developed countries, other low-income countries, and lower middle-income countries and territories.

The secondary objectives of the programme are to:

  • Strengthen internationally competitive and sustainable research groups and institutions in Norway;
  • Strengthen national and international research collaboration and partnerships;
  • Strengthen capacity of research groups and institutions in LLMICs by supporting collaborative research and training, and
  • Increase awareness of the need for global health research among policymakers, researchers and the general public.

The programme has a wide scope, but will give the highest priority to projects in the following thematic areas:

  • Prevention and treatment of, and diagnostics for, communicable diseases, particularly vaccine and vaccination research;
  • Family planning, reproductive, maternal, newborn, child and adolescent health;
  • Health systems and health policy research;
  • Innovation in technology and methods development.

Research that cuts across two or more of the four thematic areas above is encouraged.

Implementation research is key to the effective deployment and scaling-up of efficacious health interventions. The programme may fund research and innovation along the whole R&D value chain as long as it is relevant for the primary objective of the programme. Multidisciplinary and interdisciplinary research approaches addressing the greatest global health challenges are particularly encouraged.

Projects with funding

At present, these projects have received funding from the GLOBVAC-programme. The overview provides access to summaries and other key information on all the projects under the programme. (The overview may contain information in Norwegian.)

This programme/activity normally accepts grant applications from:

Public and private Norwegian research institutions and Norwegian companies.

Duration:

2012-2020

Overall budget:

The annual budget of the programme is NOK 65 million during the 2018 to 2020 period.

Contact